Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10‐plex quantitative proteomics and phosphoproteomics

Publisher： John Wiley & Sons Inc

E-ISSN： 1615-9861|15|2-3|462-473

ISSN： 1615-9853

Source： PROTEOMICS, Vol.15, Iss.2-3, 2015-01, pp. : 462-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 133, Iss. 5, 2015-06 ,pp. : 750-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative proteomics using SILAC: Principles, applications, and developments

By  

PROTEOMICS, Vol. 15, Iss. 18, 2015-09 ,pp. : 3175-3192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative proteomics using SILAC: Principles, applications, and developments

By  

PROTEOMICS, Vol. 1615-9853, Iss. 18, 2015-09 ,pp. : 3175-3192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focus on Quantitative Proteomics

By  

PROTEOMICS, Vol. 1615-9853, Iss. 18, 2015-09 ,pp. : 3101-3103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focus on Quantitative Proteomics

By  

PROTEOMICS, Vol. 15, Iss. 18, 2015-09 ,pp. : 3101-3103

John Wiley & Sons Inc

Access to resources Recommend Favorite